Affinity Chromatography Market Report 2026

The affinity chromatography market size has grown strongly in recent years. It will grow from $3.68 billion in 2025 to $3.93 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to expansion of biopharmaceutical manufacturing activities, increasing research on recombinant proteins, wider adoption of affinity-based separation methods, growth of academic and research institutions, availability of advanced chromatography materials.

The affinity chromatography market size is expected to see strong growth in the next few years. It will grow to $5.07 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing demand for monoclonal antibodies, rising investments in biologics development, expansion of personalized medicine research, growing focus on downstream process optimization, increasing adoption of single-use chromatography systems. Major trends in the forecast period include increasing use of high-specificity purification techniques, rising adoption of protein-based therapeutics, growing demand for pre-packed chromatography columns, expansion of biopharmaceutical research activities, enhanced focus on process scalability and reproducibility.

The rising demand for biopharmaceuticals is expected to drive the growth of the affinity chromatography market going forward. Biopharmaceuticals are medicinal products derived from biological sources, such as living organisms or cells, and are used to prevent, diagnose, or treat diseases. The demand for biopharmaceuticals is increasing because they provide highly targeted and effective treatments for complex conditions, such as cancer and autoimmune disorders, improving patient outcomes where conventional drugs may be less effective. Affinity chromatography enables the precise and efficient purification of complex biomolecules, including proteins and antibodies, which is crucial for producing high-quality biopharmaceutical products. For instance, in July 2025, according to Sartorius, a Germany-based international life science technology company, global sales of biopharmaceutical drugs increased by approximately 9% to reach USD 458 billion in 2024, up from the previous year, accounting for 41% of the total pharmaceutical market compared with 40% in 2023. Therefore, the rising demand for biopharmaceuticals is expected to fuel the growth of the affinity chromatography market.

Key companies operating in the affinity chromatography market are concentrating on developing advanced solutions, such as next-generation affinity chromatography units, for rapid, flexible, and efficient antibody purification in laboratory environments. These units represent a significant advancement in purification systems, offering higher specificity, scalability, and automation, often integrating novel ligands and improved resin materials to meet the evolving needs of biopharmaceutical research and production. For instance, in October 2024, Sartorius, a Germany-based pharmaceutical company, launched the Sartobind Rapid A Lab, a Protein A affinity chromatography unit. It features the fastest Protein A matrix available, delivering exceptional productivity and transforming antibody purification. Designed for research scientists, it provides a plug-and-play system suitable for benchtop purification and rapid cycling without requiring buffer degassing. Its membrane resists clogging and maintains consistent backpressure, enabling reliable use with syringes, pumps, or chromatography systems for up to 100 purification cycles. Over its consumable lifetime, it achieves up to 17 times higher antibody yields compared with traditional resin columns.

In July 2024, Repligen, a US-based life sciences company, acquired Tantti Laboratory Inc. for an undisclosed amount. Through this acquisition, Repligen gains access to Tantti’s macroporous chromatography beads, which are used for purifying viral vectors, viruses, nucleic acids, and other advanced modalities. This acquisition is intended to expand and strengthen Repligen’s offerings in the rapidly growing field of new modality bioprocessing. Tantti Laboratory Inc. is a Taiwan-based provider of affinity chromatography products.

Major companies operating in the affinity chromatography market are Thermo Fisher Scientific, Merck KGaA, GE Healthcare Life Sciences, MilliporeSigma, Lonza Group Ltd., Agilent Technologies, Cytiva, Sartorius AG, Tosoh Bioscience, Waters Corporation, Bio-Rad Laboratories, Pall Corporation, Promega Corporation, Biotage, KNAUER Wissenschaftliche Geräte GmbH, BioWorks Inc., BIA Separation, JNC Corporation.

North America was the largest region in the affinity chromatography market in 2025. The regions covered in the affinity chromatography market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the affinity chromatography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the affinity chromatography market by increasing costs of imported resins, columns, ligands, magnetic beads, and precision laboratory equipment. Pharmaceutical and biotechnology companies in North America and Europe are most affected due to reliance on specialized imported consumables, while Asia-Pacific faces higher costs for research exports. These tariffs are increasing operational expenses and research costs. However, they are also encouraging regional production of chromatography consumables, local supplier development, and innovation in reusable and cost-efficient purification technologies.

The affinity chromatography market research report is one of a series of new reports that provides affinity chromatography market statistics, including affinity chromatography industry global market size, regional shares, competitors with a affinity chromatography market share, detailed affinity chromatography market segments, market trends and opportunities, and any further data you may need to thrive in the affinity chromatography industry. This affinity chromatography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Affinity chromatography is a highly selective separation technique used to isolate specific molecules from complex mixtures based on unique biological interactions. This method depends on the specific binding affinity between a target molecule and a complementary binding partner that is immobilized on a solid support.

The primary products of affinity chromatography include resins or gels, columns, magnetic beads, reagents and consumables, and accessories. Resins or gels are engineered to bind selectively to target molecules through attached ligands, facilitating the separation and purification process. Techniques used in this method include immobilized metal affinity chromatography, protein A, G, or L affinity chromatography, bio-specific affinity chromatography, and others. Affinity chromatography is applied for biomolecule purification and chromatographic separation and is utilized by end users such as pharmaceutical and biotechnology companies, research institutes, and academic institutions.

The affinity chromatography market consists of revenues earned by entities by providing services such as custom ligand development, column packing and preparation, protein purification services, and process optimization. The market value includes the value of related goods sold by the service provider or included within the service offering. The affinity chromatography market also includes sales of chromatography media and supports, elution buffers, affinity tags, and labeling kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.